Although BNP serves as a biomarker for diagnosing, risk stratifying, and managing heart failure in adults, its applications in neonates and infants undergoing surgical repair or palliation of congenital heart defects remain unestablished (10). The gene discussed is NPPB; the disease is congenital heart disease.